Te­va boots its R&D chief; Iron­wood grows the C-suite and In­ter­cept taps new EVP of re­search

→ In the first ma­jor C-suite over­haul un­der new CEO Kåre Schultz, trou­bled Te­va is part­ing ways with R&D chief Michael Hay­den, Glob­al Spe­cial­ty Med­i­cines head Rob Ko­re­mans, and Glob­al Gener­ic Med­i­cines Group leader Di­pankar Bhat­tachar­jee by the end of the year. A num­ber of staffers are be­ing pro­mot­ed to fill the va­can­cies, in­clud­ing Michael Mc­Clel­lan, who will be­come CFO, and Hafrun Fridriks­dot­tir, the new EVP of glob­al R&D.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER